Coppell-based Recuro Health has closed a $47 million Series B investment round that includes both new and existing investors, including ARCH Venture Partners, the Flippen Group, GPG Ventures, 4D Capital, and others.
Recuro is an integrated digital health solutions company designed to transition the U.S. healthcare system from a reactive, disease-focused model to a proactive care approach.
The company said it will use the proceeds to advance and scale its Digital Medical Home, which includes diagnostic-enabled Virtual Primary Care and Virtual Behavioral Health Solutions that are tailored to fit the healthcare needs of any population.
Integrating advanced science, data, at-home diagnostics, and targeted genomics
The Digital Medical Home care model integrates advanced science, data, at-home diagnostics, and targeted genomics for cancer screening and pharmacogenomics to better inform integrated care, the company said.
“The continued support of our investors is a clear sign of their confidence in our mission,” CEO and founder Michael Gorton said in a statement. “We have an extraordinary team at Recuro dedicated to evolving healthcare to be more proactive and personal, resulting in improved outcomes, better patient engagement and lower costs. In this next phase of our Company growth and expansion, we’re committed to building upon the success of our Digital Medical Home and continuing to advance the next generation of digital care services.”
‘The intersection of science, diagnostics and digital health’
Recuro’s digital health solutions are available nationwide and used by millions of members, the company said.
“Recuro is proving to be the best of breed in the intersection of science, diagnostics and digital health. This nimble organization has the ability to quickly respond to market changes, scale its tech-enabled services and close gaps in care that improve population health,” Robert Nelsen, co-founder and managing director of ARCH Venture Partners, said in a statement. “We see significant opportunities for exceptional growth and continued success.”
Recuro was founded in 2021 and has garnered industry recognition as a pioneer in developing innovative digital solutions that integrate Virtual Primary Care and Urgent Care, Behavioral Health, at-home lab testing, genomics as well as a suite of enabling capabilities such as care navigation, data analytics, quality and guided referrals.
Dallas Innovates featured CEO Gorton, the co-founder of Teladoc, in its 2023 Future 50 for his work at Recuro.
Get on the list.
Dallas Innovates, every day.
Sign up to keep your eye on what’s new and next in Dallas-Fort Worth, every day.